Study title: Serial blood lactate measurements predict early mortality following neonatal repair or palliation for complex congenital heart disease - Charpie JR et al. - 1999 (Circulation suppl 1, 1999, 100 (18) 1399)Serial blood lactate measurements predict early mortality following neonatal repair or palliation for complex congenital heart disease - Charpie JR et al. - 1999 (Circulation suppl 1, 1999, 100 (18) 1399)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Cardiovascular Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: MILRINONE | |||||
ATC code: C01CE02 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | Y | - | - | - |